Explore chapters and articles related to this topic
Coronary Artery Disease
Published in Stephen T. Sinatra, Mark C. Houston, Nutritional and Integrative Strategies in Cardiovascular Medicine, 2022
Nattokinase is extracted from the traditional fermented soy food called natto. It was believed by many to contribute to the low incidence of CHD in Japan. It makes sense since nattokinase not only helps to eliminate clots, but also reduces the tendency to form thick, sludgy blood and thus decreases the incidence of heart attack and stroke.
Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles
Published in Drug Delivery, 2020
Heba S. Elsewedy, Bandar E. Al Dhubiab, Mahmoud A. Mahdy, Hanan M. Elnahas
NPs morphology was investigated using SEM; Figure 3(A) shows the size distribution of the selected BRU-loaded NPs namely NP6 and Figure 3(B) shows representative images of same preparation (NP6). The NPs possessed smooth surfaces and exhibited spherical shapes with separated particles or aggregation, which confirmed the suitability of the parameters selected for NP preparation. Our results are in accordance with the findings of Prakash et al. (2017), which confirmed the spherical shape and smooth surfaces of PLGA-encapsulated nattokinase polymeric NPs prepared with PVA.
Review of Vitreopapillary Traction Syndrome
Published in Neuro-Ophthalmology, 2020
Rami S. Gabriel, Chantal J. Boisvert, Mitul C. Mehta
Other pharmacologic agents that have been investigated include enzymatic agents such as collagenase, chondroitinase, hyaluronidase, dispase, nattokinase, autologous plasmin, plasminogen activators, and non-enzymatic agents such as RGP peptides.28 Currently, there are no known studies concerning pharmacologic agents for VPT syndrome. However, depending on the results of future studies for VMT, pharmacological therapeutics could prove a promising avenue for the treatment of VPT cases on the border of requiring surgery.